About us
Our founder and CEO
Shams Choudhury:
Former MHRA GDP inspector and Responsible Person
PharmaSight was founded by Shams Choudhury in London, UK, with a vision to provide world-class consultancy services in pharmaceutical compliance and logistics. As a former MHRA GDP Inspector, Shams brings extensive experience working across the pharmaceutical supply chain, including distributing medicines across various verticals. He has been directly responsible for managing supply chains and collaborating with forwarders, exporters, logistics providers, and pharmaceutical distributors.
Shams’ experience also includes working with global regulators such as the FDA, UAE MOH, and TGA. His comprehensive understanding of the supply chain, combined with his regulatory expertise, enables PharmaSight to offer practical, tailored solutions that address the unique challenges faced by pharmaceutical businesses worldwide.
Get in touch with us:
info@pharmasight.net
How can we help you?
Our company offers a range of formal and professional services tailored to meet the needs of businesses in the pharmaceutical industry. Our team specializes in conducting mock GDP inspections and audits, providing companies with a comprehensive evaluation of their practices and ensuring compliance with industry regulations. Additionally, we offer expert regulatory consultancy services, assisting businesses in navigating the complex landscape of global medicines distribution. We provide valuable insights and guidance to help companies meet regulatory requirements and optimize their distribution processes.
Expert insights..
Our Leadership Team
At PharmaSight International, our greatest asset is our people. We have built a powerful network of regulatory affairs specialists, GxP consultants, former inspectors, quality professionals, and supply chain experts, supported by a trusted community of contractors and partners spanning the globe. Together, we combine deep technical expertise with real-world regulatory experience to deliver practical, tailored solutions — giving our clients access to a breadth of knowledge that goes far beyond a traditional consultancy.
Adnan Ahmed
Director, Clinical Regulatory Affairs
Adnan has broad regulatory expertise spanning CTAs, INDs, MAAs and BLAs across EU, US and international markets. Experienced in GCP, pharmacovigilance, paediatric strategies, orphan drug designations and scientific advice, with a strong track record in oncology, biologics and early-phase development at both biotech and large pharma.
Fouzia Naveed
Director, Regulatory Operations & Quality
Fouzia brings regulatory expertise across product authorisations, lifecycle CMC variations, GCP clinical trial applications and GDP compliance. Experienced in EU, UK and international submissions spanning oncology, rare disease and medical devices, with additional expertise in pharmacovigilance, quality management and responsible person activities.
Joseph Irwin
Director, Regulatory Strategy & Scientific Affairs
Joseph has 35+ years across clinical regulatory strategy, GCP, pharmacovigilance and product authorisations in the EU, US and global markets. A specialist in CTAs, INDs, MAAs and BLAs spanning orphan diseases, oncology, neurology and paediatric medicines, with extensive CHMP, EMA scientific advice and post-authorisation experience.
What our Clients Say
The mock GDP inspection performed by Shams highlighted key non-conformances in our GDP processes and helped us to implement swift corrective actions before inspection.
The QMS development service helped us establish a robust quality management system that enhanced our overall operational efficiency. Pharmasight helped to design and write our SOPs and implement training across our team who have since become more quality focused.
Using PharmasSight for their expert advice in distributing medicines globally was instrumental in ensuring we could get medicines to key clients across the Middle East. The guidance on exports, obtaining relevant permits from the Home Office and ensuring customs clearance in the region was invaluable.